0001532023-24-000008.txt : 20240522
0001532023-24-000008.hdr.sgml : 20240522
20240522181714
ACCESSION NUMBER: 0001532023-24-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240522
DATE AS OF CHANGE: 20240522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gangolli Julian S
CENTRAL INDEX KEY: 0001532023
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 24974695
MAIL ADDRESS:
STREET 1: 4955 BASELINE AVENUE
CITY: SANTA YNEZ
STATE: CA
ZIP: 93460
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821080209
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
4
1
wk-form4_1716416222.xml
FORM 4
X0508
4
2024-05-20
0
0001711279
Krystal Biotech, Inc.
KRYS
0001532023
Gangolli Julian S
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
1
0
0
0
0
Common Stock
2024-05-20
4
M
0
20000
22.75
A
20000
D
Common Stock
2024-05-20
4
S
0
10930
163.7063
D
9070
D
Common Stock
2024-05-20
4
S
0
7090
164.3413
D
1980
D
Common Stock
2024-05-20
4
S
0
1980
165.7576
D
0
D
Stock Option (Right to Buy)
22.75
2024-05-20
4
M
0
20000
0
D
2029-03-01
Common Stock
20000
0
D
The transaction was executed in multiple trades ranging from $163.080 to $164.065. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $164.085 to $164.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The transaction was executed in multiple trades ranging from $165.160 to $166.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
The options were awarded on March 1, 2019 and vested monthly over a three-year period.
/s/ Krish Krishnan, as attorney-in-fact for Julian S. Gangolli
2024-05-22